Lenz Robert A.
SEC insider (Form 3/4/5 filer). CIK 0001992908. Director at NovaBridge Biosciences (NBP) and 2 other issuers. 13 reported Form 4/5 transactions since Sep 2024; latest on Aug 22, 2026. Located in ROCKVILLE, MD.
Companies Lenz Robert A. has filed insider reports for
- NovaBridge Biosciences (NBP): Director
- LB PHARMACEUTICALS INC (LBRX): Director
- Neumora Therapeutics, Inc. (NMRA): Officer, Head of R&D
Lenz Robert A.
CIK: 0001992908
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Aug 22, 2026NBP
NovaBridge Biosciences
ExerciseDirect17.2K shares- - Jun 3, 2026LBRX
LB PHARMACEUTICALS INC
AwardDirectStock Option (Right to Buy)
12.5K shares- - Mar 6, 2026LBRX
LB PHARMACEUTICALS INC
AwardDirectStock Option (Right to Buy)
20K shares- - Feb 18, 2025NMRA
Neumora Therapeutics, Inc.
SaleDirect5.6K shares at avg. $1.67$9K - Feb 13, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
502.9K shares- - Feb 13, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
100K shares- - Feb 13, 2025NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
502.9K shares- - Feb 13, 2025NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
100K shares- - Oct 10, 2024NMRA
Neumora Therapeutics, Inc.
SaleDirect8.3K shares at avg. $15.09$125K - Oct 9, 2024NMRA
Neumora Therapeutics, Inc.
SaleDirect5.6K shares at avg. $15.01$84K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 22, 2026 |  NBP NovaBridge Biosciences | Exercise | 17,218 | - | $0 | Direct |
| Jun 3, 2026 |  LBRX LB PHARMACEUTICALS INC | Award Stock Option (Right to Buy) | 12,500 | - | - | Direct |
| Mar 6, 2026 | LBRX LB PHARMACEUTICALS INC | Award Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| Feb 18, 2025 |  NMRA Neumora Therapeutics, Inc. | Sale | 5,614 | $1.67 | $9,383 | Direct |
| Feb 13, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 502,934 | - | - | Direct |
| Feb 13, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 100,000 | - | - | Direct |
| Feb 13, 2025 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 502,934 | - | - | Direct |
| Feb 13, 2025 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 100,000 | - | - | Direct |
| Oct 10, 2024 | NMRA Neumora Therapeutics, Inc. | Sale | 8,260 | $15.09 | $124,603 | Direct |
| Oct 9, 2024 | NMRA Neumora Therapeutics, Inc. | Sale | 5,563 | $15.01 | $83,507 | Direct |
1-10 of 13 transactions